Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin F Gibson

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Thorax|October 16, 2019
Risk factors for disease progression in idiopathic pulmonary fibrosisGanesh Raghu, Brett Ley, Kevin K Brown, et al.
The European Respiratory Journal|January 30, 2025
Accelerated epigenetic ageing worsens survival and mediates environmental stressors in fibrotic interstitial lung diseaseGillian C Goobie, Daniel-Costin Marinescu, Ayodeji Adegunsoye, et al.
American Journal of Respiratory and Critical Care Medicine|June 20, 2025
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung DiseaseGillian C Goobie, Najmeh Assadinia, Chen Xi Yang, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
Plos One|March 5, 2011
The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosisJianmin Xue, Bernadette R Gochuico, Ahmad Samer Alawad, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 22, 2021
Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated diseaseJonathan K Alder, Rachel M Sutton, Carlo J Iasella, et al.
Thorax|December 11, 2020
Gene coexpression networks reveal novel molecular endotypes in alpha-1 antitrypsin deficiencyJen-Hwa Chu, Wenlan Zang, Milica Vukmirovic, et al.
JAMA|May 23, 2013
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosisAnna L Peljto, Yingze Zhang, Tasha E Fingerlin, et al.
The European Respiratory Journal|November 2, 2023
Increased expression of CXCL6 in secretory cells drives fibroblast collagen synthesis and is associated with increased mortality in idiopathic pulmonary fibrosisHarinath Bahudhanapati, Jiangning Tan, Rosa Marie Apel, et al.
Journal of Extracellular Biology|June 28, 2024
Plasma extracellular vesicle proteins as promising noninvasive biomarkers for diagnosis of idiopathic pulmonary fibrosisRaju S R Adduri, Kai Cai, Karen Velasco-Alzate, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Thorax|October 16, 2019
Risk factors for disease progression in idiopathic pulmonary fibrosisGanesh Raghu, Brett Ley, Kevin K Brown, et al.
The European Respiratory Journal|January 30, 2025
Accelerated epigenetic ageing worsens survival and mediates environmental stressors in fibrotic interstitial lung diseaseGillian C Goobie, Daniel-Costin Marinescu, Ayodeji Adegunsoye, et al.
American Journal of Respiratory and Critical Care Medicine|June 20, 2025
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung DiseaseGillian C Goobie, Najmeh Assadinia, Chen Xi Yang, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
Plos One|March 5, 2011
The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosisJianmin Xue, Bernadette R Gochuico, Ahmad Samer Alawad, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 22, 2021
Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated diseaseJonathan K Alder, Rachel M Sutton, Carlo J Iasella, et al.
Thorax|December 11, 2020
Gene coexpression networks reveal novel molecular endotypes in alpha-1 antitrypsin deficiencyJen-Hwa Chu, Wenlan Zang, Milica Vukmirovic, et al.
JAMA|May 23, 2013
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosisAnna L Peljto, Yingze Zhang, Tasha E Fingerlin, et al.
The European Respiratory Journal|November 2, 2023
Increased expression of CXCL6 in secretory cells drives fibroblast collagen synthesis and is associated with increased mortality in idiopathic pulmonary fibrosisHarinath Bahudhanapati, Jiangning Tan, Rosa Marie Apel, et al.
Journal of Extracellular Biology|June 28, 2024
Plasma extracellular vesicle proteins as promising noninvasive biomarkers for diagnosis of idiopathic pulmonary fibrosisRaju S R Adduri, Kai Cai, Karen Velasco-Alzate, et al.
Pageof 8